Idexx Laboratories (IDXX) Long-Term Deferred Tax (2016 - 2018)

Idexx Laboratories has reported Long-Term Deferred Tax for 3 years, with the latest figure at $9.8 million in Q1 2018.

• On a quarterly basis, Long-Term Deferred Tax rose 67.43% year-over-year to $9.8 million in Q1 2018; TTM through Mar 2018 was $9.8 million, a 67.43% increase from a year earlier, with the FY2017 full-year figure at $7.7 million, up 34.89% from the prior year.
• Long-Term Deferred Tax was $9.8 million for Q1 2018 at Idexx Laboratories, up from $7.7 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $9.8 million in Q1 2018, with the low at $5.7 million in Q4 2016.
• Average Long-Term Deferred Tax over 3 years is $7.3 million, with a median of $7.2 million recorded in 2017.
• The sharpest annual moves came in 2017 and 2018: Long-Term Deferred Tax soared 34.89% in 2017, then surged 67.43% in 2018.
• Over 3 years, Long-Term Deferred Tax stood at $5.7 million in 2016, then surged by 34.89% to $7.7 million in 2017, then advanced by 27.6% to $9.8 million in 2018.
• The last three Long-Term Deferred Tax figures came in at $9.8 million (Q1 2018), $7.7 million (Q4 2017), and $7.9 million (Q3 2017), per Business Quant data.